Impact of Insurance Status on the Day of Admission and Clinical Outcome on Acute Myeloid Leukemia (AML)Patients

被引：0
|
作者：
Ahmad, Bilal [1 ]
Maymani, Hossein [1 ]
Saeed, Haseeb [1 ]
Khawandanah, Mohamad [1 ]
Srour, Samer A. [1 ]
Machiorlatti, Michael G. [2 ]
Asch, Adam S. [1 ]
Cherry, Mohamad [1 ]
机构：
[1] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA
[2] Univ Oklahoma, Hlth Sci Ctr, Coll Publ Hlth, Oklahoma City, OK USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] IMPACT OF INSURANCE STATUS ON THE DAY OF ADMISSION AND CLINICAL OUTCOME IN ACUTE MYELOID LEUKEMIA (AML) PATIENTS
    Ahmad, B.
    Pierson, N.
    Maymani, H.
    Khawandanah, M.
    Srour, S.
    Asch, A.
    Cherry, M.
    Saeed, H.
    Machiorlatti, M.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2015, 63 (04) : 682 - 682
  • [2] Impact of CRi on the Outcome of Elderly Patients with Untreated Acute Myeloid Leukemia (AML)
    Etienne, Anne
    Charbonnier, Aude
    Prebet, Thomas
    Coso, Diane
    D'Incan, Evelyne
    Doglio, Marie-Francoise
    Sainty, Daniele
    Mozziconacci, Marie-Joelle
    Rey, Jerome
    Vey, Norbert
    BLOOD, 2008, 112 (11) : 1027 - 1027
  • [3] Clinical Impact of Change of FLT3 Mutation Status in Acute Myeloid Leukemia (AML) Patients
    Warren, M.
    Luthra, R.
    Yin, C. C.
    Ravandi, F.
    Medeiros, L. J.
    Zuo, Z.
    MODERN PATHOLOGY, 2012, 25 : 379A - 379A
  • [4] Clinical Impact of Change of FLT3 Mutation Status in Acute Myeloid Leukemia (AML) Patients
    Warren, M.
    Luthra, R.
    Yin, C. C.
    Ravandi, F.
    Medeiros, L. J.
    Zuo, Z.
    LABORATORY INVESTIGATION, 2012, 92 : 379A - 379A
  • [5] Clinical Impact of CD200 Expression on Outcome of Acute Myeloid Leukemia (AML)
    Girshova, Larisa
    Shatilova, Aleksina
    Budaeva, Irina
    Matvienko, Yulia
    Levchuk, Ksenia
    Mirolubova, Julia
    Alexeeva, Julia
    Lomaia, Elza
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S294 - S295
  • [6] Clinical impact of genetic features in Acute Myeloid Leukemia (AML)
    Doehner, K.
    Gaidzik, V., I
    Paschka, P.
    Schlenk, R. F.
    Doehner, H.
    ONKOLOGIE, 2012, 35 : 155 - 155
  • [7] Treatment outcome of acute myeloid leukemia (AML) in HIV plus patients
    Dy, Irene Ang
    Patchett, Matthew
    McDonald, Alicia
    Wiernik, Peter H.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [8] The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML
    Kayser, Sabine
    Doehner, Konstanze
    Krauter, Juergen
    Koehne, Claus-Henning
    Horst, Heinz A.
    Held, Gerhard
    von Lilienfeld-Toal, Marie
    Wilhelm, Sibylla
    Kuendgen, Andrea
    Goetze, Katharina
    Rummel, Mathias
    Nachbaur, David
    Schlegelberger, Brigitte
    Goehring, Gudrun
    Spaeth, Daniela
    Morlok, Carina
    Zucknick, Manuela
    Ganser, Arnold
    Doehner, Hartmut
    Schlenk, Richard F.
    BLOOD, 2011, 117 (07) : 2137 - 2145
  • [9] Impact of Day 28 Absolute Lymphocyte Count on Outcome of Adult Patients with Acute Myeloid Leukemia
    Bumma, Naresh
    Ai, Jing
    Jia, Xuefei
    Hobson, Sean
    Abounader, Donna
    Sekeres, Mikkael A.
    Kalaycio, Matt E.
    Sobecks, Ron
    Gerds, Aaron
    Hamilton, Betty K.
    Mukherjee, Sudipto
    Carraway, Hetty E.
    Tench, Shawnda
    Copelan, Edward A.
    Advani, Anjali S.
    BLOOD, 2014, 124 (21)
  • [10] Impact of Health Care Insurance Status on Treatment Outcomes of Acute Myeloid Leukemia
    Srour, Samer A.
    Machiorlatti, Michael
    Pierson, Namali T.
    Bhutta, Usman Z.
    Cherry, Mohamad
    Selby, George B.
    Thompson, David M.
    Vesely, Sara K.
    Kurkjian, Carla D.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (07): : 450 - +
12345